From: Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
Patient characteristic | IP ( +) | IP (−) | P |
---|---|---|---|
Participants, n | n = 13 | n = 13 | |
Age (years) | 69.0 (68.0–74.0) | 68.0 (65.5–72.5) | 0.254 |
Sex, male/female | 12/1 | 11/2 | 0.535 |
ECOG PS | |||
0/1/2 | 7/4/2 | 7/5/1 | 0.798 |
Smoking history | |||
Pack-years | 50.0 (45.0–63.0) | 47.0 (42.5–73.5) | 0.938 |
COPD | |||
+/− | 12/1 | 11/2 | 0.535 |
Clinical stage | |||
IIIA/IIIB/IVA/IVB | 1/0/7/5 | 1/0/10/2 | 0.394 |
Histology | 0.489 | ||
Adenocarcinoma | 11 | 12 | |
Squamous cell carcinoma | 1 | 1 | |
Others | 1 | 0 | |
KL-6, U/mL | 949.0 (446.0–1683.0) | 461.0 (214.0–771.0) | 0.039 |
CEA | 10.5 (5.5–21.6) | 42.7 (6.1–307.4) | 0.127 |
CYFRA | 9.7 (3.5–14.3) | 5.2 (1.7–5.8) | 0.036 |